Related references
Note: Only part of the references are listed.Imaging endogenous macrophage iron deposits reveals a metabolic biomarker of polarized tumor macrophage infiltration and response to CSF1R breast cancer immunotherapy
Avigdor Leftin et al.
SCIENTIFIC REPORTS (2019)
The PD-1/PD-L1 Axis in HER2+Ductal Carcinoma In Situ (DCIS) of the Breast
Julianne M. Ubago et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2019)
Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer
Elham Safarzadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
Nehad M. Ayoub et al.
BREAST CANCER-TARGETS AND THERAPY (2019)
Tumor infiltrating lymphocytes in early breast cancer
Giancarlo Pruneri et al.
BREAST (2018)
Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ
Anthony J. Maxwell et al.
EJSO (2018)
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Peter Savas et al.
NATURE MEDICINE (2018)
High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patients
Pablo Mando et al.
ONCOTARGETS AND THERAPY (2018)
Primed atypical ductal hyperplasia-associated fibroblasts promote cell growth and polarity changes of transformed epithelium-like breast cancer MCF-7 cells via miR-200b/c-IKKβ signaling
Yan Sun et al.
CELL DEATH & DISEASE (2018)
Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape
Tanjina Kader et al.
BREAST CANCER RESEARCH (2018)
High mammographic density in women is associated with protumor inflammation
Cecilia W. Huo et al.
BREAST CANCER RESEARCH (2018)
Breast Cancer Risk Associated With Atypical Hyperplasia and Lobular Carcinoma In Situ Initially Diagnosed on Core-Needle Biopsy
Alana R. Donaldson et al.
CANCER (2018)
Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast
Michael J. Campbell et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer
Sathana Dushyanthen et al.
NATURE COMMUNICATIONS (2017)
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition
Carlos R. Gil Del Alcazar et al.
CANCER DISCOVERY (2017)
Macrophages promote the progression of premalignant mammary lesions to invasive cancer
Emily C. Carron et al.
ONCOTARGET (2017)
Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
Kylie L. Gorringe et al.
FRONTIERS IN ONCOLOGY (2017)
Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features
Shona Hendry et al.
CLINICAL CANCER RESEARCH (2017)
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
Sherene Loi et al.
CLINICAL CANCER RESEARCH (2016)
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00
Giancarlo Pruneri et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Infiltrating Macrophages Induce ERα Expression through an IL17A-mediated Epigenetic Mechanism to Sensitize Endometrial Cancer Cells to Estrogen
Chengcheng Ning et al.
CANCER RESEARCH (2016)
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
Ashley Cimino-Mathews et al.
HUMAN PATHOLOGY (2016)
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
H. Raza Ali et al.
PLOS MEDICINE (2016)
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
Xiaofeng Dai et al.
JOURNAL OF CANCER (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration
Kingsley O. Osuala et al.
BMC CANCER (2015)
Relevance of tumor-infiltrating lymphocytes in breast cancer
Sathana Dushyanthen et al.
BMC MEDICINE (2015)
Clinical implications of the intrinsic molecular subtypes of breast cancer
Aleix Prat et al.
BREAST (2015)
Mammary gland development: cell fate specification, stem cells and the microenvironment
Jamie L. Inman et al.
DEVELOPMENT (2015)
Genetically modified T cells in cancer therapy: opportunities and challenges
Michaela Sharpe et al.
DISEASE MODELS & MECHANISMS (2015)
Atypical Hyperplasia of the Breast - Risk Assessment and Management Options
Lynn C. Hartmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer
Christine Pasero et al.
ONCOTARGET (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up
Melinda E. Sanders et al.
MODERN PATHOLOGY (2015)
Human breast cancer cells educate macrophages toward the M2 activation status
Sofia Sousa et al.
BREAST CANCER RESEARCH (2015)
Heterogeneity in the Differentiation and Function of CD8+ T Cells
Hans-Willi Mittruecker et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2014)
Immune cell quantitation in normal breast tissue lobules with and without lobulitis
Amy C. Degnim et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
S. Muenst et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
Y. Yu et al.
BRITISH JOURNAL OF CANCER (2014)
Advantages and clinical applications of natural killer cells in cancer immunotherapy
Erik Ames et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
B cell Biology: An Overview
Hermann Eibel et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2014)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
M1 and M2 Macrophages: The Chicken and the Egg of Immunity
Charles D. Mills et al.
JOURNAL OF INNATE IMMUNITY (2014)
The Promotion of Breast Cancer Metastasis Caused by Inhibition of CSF-1R/CSF-1 Signaling Is Blocked by Targeting the G-CSF Receptor
Agnieszka Swierczak et al.
CANCER IMMUNOLOGY RESEARCH (2014)
The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
S. Muenst et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
NK cell-based immunotherapy for malignant diseases
Min Cheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients
Maria Libera Ascierto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
Makiko Ono et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade
Leisha A. Emens
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Cancer immunoediting by the innate immune system in the absence of adaptive immunity
Timothy O'Sullivan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Differentiation and gene expression profile of tumor-associated macrophages
Astrid Schmieder et al.
SEMINARS IN CANCER BIOLOGY (2012)
HIF-1 versus HIF-2 - Is one more important than the other?
Agnieszka Loboda et al.
VASCULAR PHARMACOLOGY (2012)
2011: the immune hallmarks of cancer
Federica Cavallo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
Purevdorj B. Olkhanud et al.
CANCER RESEARCH (2011)
Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics
Rita A. Mukhtar et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
Sergio A. Quezada et al.
IMMUNOLOGICAL REVIEWS (2011)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
Sahar M. A. Mahmoud et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
Leukocytes in Mammary Development and Cancer
Lisa M. Coussens et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial
S. E. Pinder et al.
BRITISH JOURNAL OF CANCER (2010)
Histological, molecular and functional subtypes of breast cancers
Gautam K. Malhotra et al.
CANCER BIOLOGY & THERAPY (2010)
T regulatory cells and the control of alloimmunity: from characterisation to clinical application
Joanna Wieckiewicz et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Breast cancer precursors revisited: molecular features and progression pathways
Maria A. Lopez-Garcia et al.
HISTOPATHOLOGY (2010)
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
Carsten Denkert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Role of macrophages in tumour progression
K. S. Siveen et al.
IMMUNOLOGY LETTERS (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Membrane-bound Fas ligand only is essential for Fas-induced apoptosis
Lorraine A. O' Reilly et al.
NATURE (2009)
Pten in stromal fibroblasts suppresses mammary epithelial tumours
Anthony J. Trimboli et al.
NATURE (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Regulation of in situ to invasive breast carcinoma transition
Min Hu et al.
CANCER CELL (2008)
The humoral immune system has a key prognostic impact in node-negative breast cancer
Marcus Schmidt et al.
CANCER RESEARCH (2008)
Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating Foxp3+ regulatory T cells
Sylvain Ladoire et al.
CLINICAL CANCER RESEARCH (2008)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observations
M. R. Hussein et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Primary T cell expansion and requires antigen presentation differentiation in vivo by B cells
Alison Crawford et al.
JOURNAL OF IMMUNOLOGY (2006)
Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer
HE Kohrt et al.
PLOS MEDICINE (2005)
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
KL Knutson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells
A Boire et al.
CELL (2005)
High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS
S Roka et al.
EJSO (2004)
TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia
NA Bhowmick et al.
SCIENCE (2004)
Current practical applications of diagnostic immunohistochemistry in breast pathology
MF Lerwill
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
Dendritic cell infiltration and prognosis of early stage breast cancer
I Treilleux et al.
CLINICAL CANCER RESEARCH (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
The diagnosis and management of pre-invasive breast disease - Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) - current definitions and classification
SE Pinder et al.
BREAST CANCER RESEARCH (2003)
Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma
T Valkovic et al.
VIRCHOWS ARCHIV (2002)
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia
RT Costello et al.
BLOOD (2002)
Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation
CD Buckley et al.
TRENDS IN IMMUNOLOGY (2001)
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
KL Talks et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
